Page last updated: 2024-08-22

tranylcypromine and reboxetine

tranylcypromine has been researched along with reboxetine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castelli, MG; Cicioni, P; Dostert, P; Strolin Benedetti, M1
Duman, RS; Eisch, AJ; Malberg, JE; Nestler, EJ1
Brunner, H; Friess, E; Pollmächer, T; Wichniak, A1
Carey, GJ; Gold, LH; Nielsen, DM1
Bajbouj, M; Danker-Hopfe, H; Gallinat, J; Hellen, F; Lang, UE; Lisanby, SH; Neu, P; Vesper, J1

Trials

1 trial(s) available for tranylcypromine and reboxetine

ArticleYear
Motor cortex excitability after vagus nerve stimulation in major depression.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Lamotrigine; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Morpholines; Motor Cortex; Neural Conduction; Neural Inhibition; Olanzapine; Paroxetine; Psychiatric Status Rating Scales; Reboxetine; Tranylcypromine; Triazines; Vagus Nerve; Valproic Acid

2007

Other Studies

4 other study(ies) available for tranylcypromine and reboxetine

ArticleYear
Reboxetine prevents the tranylcypromine-induced increase in tyramine levels in rat heart.
    Journal of neural transmission. Supplementum, 1994, Volume: 41

    Topics: Animals; Dose-Response Relationship, Drug; Heart Rate; Male; Morpholines; Myocardium; Rats; Rats, Sprague-Dawley; Reboxetine; Time Factors; Tranylcypromine; Tyramine

1994
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Dec-15, Volume: 20, Issue:24

    Topics: Animals; Antidepressive Agents; Antigens, Differentiation; Bromodeoxyuridine; Cell Count; Cell Division; Cell Survival; Fluorescent Antibody Technique; Fluoxetine; Hippocampus; Male; Morpholines; Neurons; Rats; Rats, Sprague-Dawley; Reboxetine; Tranylcypromine

2000
Successful suppression of cataplectic attacks with tramadol.
    Neurology, 2003, Sep-23, Volume: 61, Issue:6

    Topics: Aged; Biogenic Monoamines; Cataplexy; Female; Humans; Middle Aged; Monoamine Oxidase Inhibitors; Morpholines; Narcotics; Reboxetine; Receptors, Opioid; Recurrence; Sleep, REM; Substance Withdrawal Syndrome; Tramadol; Tranylcypromine; Treatment Outcome

2003
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
    European journal of pharmacology, 2004, Sep-19, Volume: 499, Issue:1-2

    Topics: Animals; Antidepressive Agents; Clorgyline; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Hindlimb Suspension; Male; Mice; Morpholines; Motor Activity; Paroxetine; Pyrazoles; Pyrimidines; Pyrroles; Reboxetine; Receptors, Corticotropin-Releasing Hormone; Selegiline; Swimming; Tranylcypromine; Triazines

2004